Christopher Bloomstran’s Validus Hold Ltd VR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-46,494
Closed -$3.14M 31
2018
Q2
$3.14M Sell
46,494
-8,716
-16% -$590K 1.97% 16
2018
Q1
$3.72M Sell
55,210
-641
-1% -$40.4K 2.59% 13
2017
Q4
$2.62M Hold
55,851
1.96% 13
2017
Q3
$2.75M Hold
55,851
2.03% 15
2017
Q2
$2.9M Hold
55,851
2.23% 15
2017
Q1
$3.15M Sell
55,851
-150
-0.3% -$8.55K 2.35% 14
2016
Q4
$3.08M Hold
56,001
2.29% 15
2016
Q3
$2.79M Hold
56,001
2.02% 16
2016
Q2
$2.72M Hold
56,001
1.97% 16
2016
Q1
$2.64M Sell
56,001
-100
-0.2% -$4.49K 1.9% 16
2015
Q4
$2.6M Hold
56,101
1.82% 17
2015
Q3
$2.53M Sell
56,101
-1,285
-2% -$58K 1.77% 16
2015
Q2
$2.52M Sell
57,386
-45
-0.1% -$1.93K 1.69% 15
2015
Q1
$2.42M Hold
57,431
1.57% 15
2014
Q4
$2.39M Sell
57,431
-100
-0.2% -$4.04K 1.53% 16
2014
Q3
$2.25M Hold
57,531
1.38% 20
2014
Q2
$2.2M Hold
57,531
1.29% 21
2014
Q1
$2.17M Hold
57,531
1.25% 21
2013
Q4
$2.32M Hold
57,531
1.32% 20
2013
Q3
$2.13M Sell
57,531
-267
-0.5% -$9.45K 1.26% 20
2013
Q2
$2.09M Buy
+57,798
New +$2.14M 1.23% 20

Christopher Bloomstran's VR Position: Q3 2018 in Review

Christopher Bloomstran sold out of Validus Hold Ltd (VR) in Q3 2018, closing a stake of 46,494 shares — an estimated $3.14M sold.

Christopher Bloomstran first reported a position in VR in Q2 2013 and held it in 21 quarters. The position peaked at $3.72M in Q1 2018. 0 funds tracked by Wall St. Rank hold VR as of Q3 2018.

  • Christopher Bloomstran reported no remaining Validus Hold Ltd position as of Q3 2018 after selling out during the quarter.
  • Christopher Bloomstran sold 46,494 Validus Hold Ltd shares in Q3 2018, an estimated $3.14M.
  • Christopher Bloomstran first reported a position in Validus Hold Ltd in Q2 2013 and held it in 21 quarters.
  • Christopher Bloomstran's Validus Hold Ltd position peaked at $3.72M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Validus Hold Ltd as of Q3 2018.

Based on Semper Augustus Investments Group's 13F filing for Q3 2018, filed 13 Nov 2018.